DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BATEFENTEROL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
BATEFENTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
1IAT42T80T
Molecule Type:
Small molecule
Molecular Formula:
C40H42ClN5O7
Molecular Weight:
740.26
AlogP:
6.43
PSA:
165.25
HBD:
6.0
HBA:
#RotB:
13.0
Source:
TIPEPIDINE
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Cough; Depressive Disorder
Unknown
TIPEPIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2260ZP67IT
Molecule Type:
Small molecule
Molecular Formula:
C15H17NS2
Molecular Weight:
275.44
AlogP:
4.34
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
2.0
Source:
VIPIVOTIDE TETRAXETAN GALLIUM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VIPIVOTIDE TETRAXETAN GALLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C49H68GaN9O16
Molecular Weight:
1108.85
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VESTIPITANT MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurokinin 1 receptor antagonist
VESTIPITANT MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
OWR424W90Q
Molecule Type:
Small molecule
Molecular Formula:
C24H28F7N3O4S
Molecular Weight:
587.56
AlogP:
5.93
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ZENOCUTUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms
ErbB-2/ErbB-3 heterodimer inhibitor
ZENOCUTUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
AE72RB1W1X
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TCH346
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TCH346
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GIMSILUMAB
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Severe Acute Respiratory Syndrome
Granulocyte-macrophage colony-stimulating factor inhibitor
GIMSILUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
8961SFA7R3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOTB07
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SOTB07
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
9-AMINOCAMPTOTHECIN
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Esophageal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms
Unknown
9-AMINOCAMPTOTHECIN
×
Maximum Phase:
2
First Approval:
None
UNII:
5MB77ICE2Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17N3O4
Molecular Weight:
363.37
AlogP:
1.66
PSA:
107.44
HBD:
2.0
HBA:
#RotB:
1.0
Source:
F901318
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
F901318
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTOFISOPAM
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome
Unknown
DEXTOFISOPAM
×
Maximum Phase:
2
First Approval:
None
UNII:
EZ15I5D6C1
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O4
Molecular Weight:
382.46
AlogP:
4.44
PSA:
61.64
HBD:
0.0
HBA:
#RotB:
6.0
Source:
URELUMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Gliosarcoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Leukemia; Melanoma
Tumor necrosis factor receptor superfamily member 9 agonist
URELUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
230902QLLC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOCIPARSTAT SODIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOCIPARSTAT SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
4O75889WF4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETIC ACID C-11
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant; Carcinoma, Hepatocellular
Unknown
ACETIC ACID C-11
×
Maximum Phase:
2
First Approval:
None
UNII:
2A9OM7IPNW
Molecule Type:
Small molecule
Molecular Formula:
C2H4O2
Molecular Weight:
59.05
AlogP:
0.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
THYMOSIN BETA 4
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
THYMOSIN BETA 4
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APILIMOD
2
Small molecule
Investigational
Unknown
Unknown
Common Variable Immunodeficiency; Crohn Disease; Severe Acute Respiratory Syndrome
1-phosphatidylinositol 3-phosphate 5-kinase inhibitor
APILIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
GFW2K84S4L
Molecule Type:
Small molecule
Molecular Formula:
C23H26N6O2
Molecular Weight:
418.5
AlogP:
3.08
PSA:
84.76
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PRS-211375
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
PRS-211375
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-448
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Hypogonadism
Unknown
TAK-448
×
Maximum Phase:
2
First Approval:
None
UNII:
YO029HR229
Molecule Type:
Small molecule
Molecular Formula:
C58H80N16O14
Molecular Weight:
1225.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LAPACHONE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Neoplasms
Unknown
LAPACHONE
×
Maximum Phase:
2
First Approval:
None
UNII:
6N4FA2QQ6A
Molecule Type:
Small molecule
Molecular Formula:
C15H14O3
Molecular Weight:
242.27
AlogP:
2.75
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CTS-1027
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Unknown
CTS-1027
×
Maximum Phase:
2
First Approval:
None
UNII:
2QD3F58224
Molecule Type:
Small molecule
Molecular Formula:
C19H20ClNO6S
Molecular Weight:
425.89
AlogP:
3.21
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
REVAPRAZAN
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
REVAPRAZAN
×
Maximum Phase:
2
First Approval:
None
UNII:
5P184180P5
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN4
Molecular Weight:
362.45
AlogP:
5.1
PSA:
41.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MIVAVOTINIB CITRATE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Lymphoma, Large B-Cell, Diffuse
Tyrosine-protein kinase SYK inhibitor
MIVAVOTINIB CITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
6ZJ8V3Q0H1
Molecule Type:
Small molecule
Molecular Formula:
C23H29FN6O8
Molecular Weight:
536.52
AlogP:
1.55
PSA:
97.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PICTILISIB
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
PI3-kinase class I inhibitor
PICTILISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
ICY00EMP8P
Molecule Type:
Small molecule
Molecular Formula:
C23H27N7O3S2
Molecular Weight:
513.65
AlogP:
2.15
PSA:
107.55
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TESETAXEL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Melanoma; Prostatic Neoplasms, Castration-Resistant; Stomach Neoplasms; Breast Neoplasms
Unknown
TESETAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
UG97LO5M8Y
Molecule Type:
Small molecule
Molecular Formula:
C46H60FN3O13
Molecular Weight:
881.99
AlogP:
4.56
PSA:
201.51
HBD:
3.0
HBA:
#RotB:
10.0
Source:
HP184
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HP184
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FIALURIDINE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Herpes Simplex
Unknown
FIALURIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
53T7IN77LC
Molecule Type:
Small molecule
Molecular Formula:
C9H10FIN2O5
Molecular Weight:
372.09
AlogP:
-1.27
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ORM-12741
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
ORM-12741
×
Maximum Phase:
2
First Approval:
None
UNII:
D26C95A960
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO2
Molecular Weight:
285.39
AlogP:
3.78
PSA:
25.61
HBD:
0.0
HBA:
#RotB:
2.0
Source:
HQP1351
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HQP1351
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TETRAHYDROPALMATINE
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
TETRAHYDROPALMATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
3X69CO5I79
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO4
Molecular Weight:
355.43
AlogP:
3.38
PSA:
40.16
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MARALIXIBAT CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Cholangitis, Sclerosing; Liver Cirrhosis, Biliary; Alagille Syndrome; Pruritus
Ileal bile acid transporter inhibitor
MARALIXIBAT CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
V78M04F0XC
Molecule Type:
Small molecule
Molecular Formula:
C40H56ClN3O4S
Molecular Weight:
710.42
AlogP:
6.62
PSA:
70.08
HBD:
1.0
HBA:
#RotB:
13.0
Source:
HYDROXYPROGESTERONE
2
Small molecule
Investigational
Unknown
Unknown
Premature Birth
Unknown
HYDROXYPROGESTERONE
×
Maximum Phase:
2
First Approval:
None
UNII:
21807M87J2
Molecule Type:
Small molecule
Molecular Formula:
C21H30O3
Molecular Weight:
330.47
AlogP:
3.84
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
EX-527
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EX-527
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C13H15ClN2O
Molecular Weight:
250.73
AlogP:
2.5
PSA:
55.12
HBD:
2.0
HBA:
#RotB:
1.0
Source:
AZD1446
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity
Neuronal acetylcholine receptor; alpha4/beta2 agonist
AZD1446
×
Maximum Phase:
2
First Approval:
None
UNII:
ANR9OP1V17
Molecule Type:
Small molecule
Molecular Formula:
C11H13ClN2O2
Molecular Weight:
240.69
AlogP:
1.22
PSA:
45.48
HBD:
1.0
HBA:
#RotB:
1.0
Source:
INCB-047986
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Hodgkin Disease; Myelodysplastic Syndromes; Arthritis, Rheumatoid
Tyrosine-protein kinase JAK1 inhibitor
INCB-047986
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPELSIBAN BESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPELSIBAN BESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H629P9T4UN
Molecule Type:
Small molecule
Molecular Formula:
C36H44N4O7S
Molecular Weight:
676.84
AlogP:
2.76
PSA:
91.84
HBD:
1.0
HBA:
#RotB:
6.0
Source:
1
2
…
126
127
128
129
130
131
132
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA